Earnings Feed
Start Free
Home/Filings/4/0001209191-11-051681
4//SEC Filing

HAHN ELLIOT F 4

Accession 0001209191-11-051681

CIK 0001301081other
View on SEC.govCompany Profile

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 4:09 PM ET

Size

9.0 KB

Accession

0001209191-11-051681

Insider Transaction Report

Form 4
Period: 2011-10-11
Pharmasset IncVRUS
HAHN ELLIOT F
Director
Transactions
  • Award

    Common Stock, $.001 par value per share

    2011-10-11+1,000→ 43,666 total
  • Award

    Stock Option (Right to Buy)

    2011-10-11+15,000→ 15,000 total
    Exercise: $83.52Exp: 2021-10-10→ Common Stock (15,000 underlying)
Holdings

  • Common Stock, $.001 par value per share

    (indirect: By Trust)
    97,790

  • Common Stock, $.001 par value per share

    (indirect: By Trust)
    97,792
Footnotes (4)
  • [F1]The restricted stock award was granted under the Company's 2007 Equity Incentive Plan, as amended. The shares subject to the restricted stock award vest on the following schedule: 25% upon grant, 25% on the first anniversary of the grant, and 6.25% quarterly thereafter.
  • [F2]The shares are owned by Elliot F. Hahn TTEE FBO Elliot F. Hahn Retained Annuity Trust 1 U/A/D 12/10/2010. Elliot F. Hahn is the sole trustee of the trust.
  • [F3]The shares are owned by Elliot F. Hahn TTEE FBO Elliot F. Hahn Retained Annuity Trust 2 U/A/D 12/10/2010. Elliot F. Hahn is the sole trustee of the trust.
  • [F4]Shares vest on the following schedule: 25% upon grant, 25% on the first anniversary of the grant, and 6.25% quarterly thereafter.

Documents

1 file

Issuer

Pharmasset Inc

CIK 0001301081

→
Entity typeother

Related Parties

1
  • filerCIK 0001032729

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:09 PM ET
Size
9.0 KB
View on SEC.gov